CMSC 2017 Coverage

In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression

In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression

The post-hoc analysis sought to identify factors predictive of relapse and disability progression in people with MS enrolled in the TRANSFORMS study.

Ocrelizumab May Improve Cognitive Function in Relapsing Multiple Sclerosis

Ocrelizumab May Improve Cognitive Function in Relapsing Multiple Sclerosis

Researchers sought to determine whether treatment with ocrelizumab improved measures of cognitive function better than interferon beta 1-a.

Teriflunomide for MS Associated With Low Rates of Infection, Lymphopenia

Teriflunomide for MS Associated With Low Rates of Infection, Lymphopenia

Initial trials of teriflunomide have demonstrated low lymphocyte counts in patients with relapsing forms of MS.

In Multiple Sclerosis, Hand Strength May Indicate Disease Status

In Multiple Sclerosis, Hand Strength May Indicate Disease Status

In patients with MS, hand function often correlates with measures of quality of life.

Multiple Sclerosis May Have Causal Link to Osteoporosis

Multiple Sclerosis May Have Causal Link to Osteoporosis

The prevalence of osteoporosis was greater in patients with MS than in matched controls.

In MS, Anxiety, Cognitive Fatigue May Affect Visual Memory

In MS, Anxiety, Cognitive Fatigue May Affect Visual Memory

Cognitive fatigue and anxiety are common symptoms reported by patients with multiple sclerosis.

Multiple Sclerosis Relapse Rate Linked to Puberty in Boys

Multiple Sclerosis Relapse Rate Linked to Puberty in Boys

Boys with onset of MS during puberty experienced an increased rate of relapse compared with boys with MS onset before or after puberty.

Upcoming Meetings

Sign Up for Free e-newsletters